Business

Normothermic Machine Perfusion Market is Going to Booming Growth 2026-2033 | TransMedics Group Inc, OrganOx Limited

The global normothermic machine perfusion market is estimated to be valued at USD 2.05 Bn in 2026 and is expected to reach USD 6.57 Bn by 2033. BURLINGAME,

articleTransmedics Group, Inc.May 7, 20264/company/transmedics-group-inc/news/normothermic-machine-perfusion-market-is-going-to-booming-growth-2026-2033-or-transmedics-group-inc-organox-limited
Normothermic Machine Perfusion Market is Going to Booming Growth 2026-2033 | TransMedics Group Inc, OrganOx Limited

About this update from Transmedics Group, Inc.

[{"type":"text","content":"Normothermic Machine Perfusion Market The global normothermic machine perfusion market is estimated to be valued at USD 2.05 Bn in 2026 and is expected to reach USD 6.57 Bn by 2033. BURLINGAME, CA, UNITED STATES, May 7, 2026 /EINPresswire.com/ -- The Global Normothermic Machine Perfusion Market is estimated to be valued at USD 2.05 Bn in 2026 and is expected to reach USD 6.57 Bn by 2033, expanding at a compound annual growth rate (CAGR) of 18.11% from 2026 to 2033. The growing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and chronic kidney disease has significantly increased the global demand for organ transplants. These conditions often lead to organ failure, creating a critical need for effective organ preservation and evaluation methods to ensure optimal donor organ viability. Get the Sample Copy of the Report at: https://www.coherentmarketinsights.com/insight/request-sample/9141 Key Takeaways By application, organ preservation segment is slated to account for 44.5% of the global normothermic machine perfusion market share in 2026. Based on organ type, kidney segment is expected to lead the market with a 32.4% share in 2026. Hospitals and surgical centers are likely to remain the leading end-users of normothermic machine perfusion, with the target segment accounting for a market share of 34.6% by 2026. North America is expected to dominate the global normothermic machine perfusion industry, accounting for a 41.4% share in 2026. Asia Pacific, with 23.5% share in 2026, is poised to emerge as the fastest growing normothermic machine perfusion market during the forecast period. Growing Demand for Organ Transplantation Fueling Market Growth Coherent Market Insights’ new normothermic machine perfusion market analysis outlines major factors driving industry growth. These include rising demand for organ transplantation, increasing demand for advanced organ preservation techniques, growing regulatory support, and technological advancements in normothermic machine perfusion systems. The global need for organ transplants is increasing due to rising prevalence of end-stage organ failure, including renal, cardiac, and liver failure. This expanding patient pool is driving demand for effective organ preservation technologies such as normothermic machine perfusion, which can improve organ viability and utilizati...

More updates from Transmedics Group, Inc.